Postdoctoral Fellowship Positions in Cancer Biology
The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center has available several postdoctoral fellowships in basic and translational cancer biology research. These fellowships are supported by our National Cancer Institute T32CA154274 training grant.
This multidisciplinary fellowship training program focuses on basic and translational cancer research with the ultimate goal of enhancing clinical oncology. The training program provides cross-disciplinary, mentored research training in cancer, and supports overall professional development through seminars, journal clubs, workshops, and career development. The program is well-suited to individuals who are highly motivated to seek broader training in addition to the traditional single lab-focused postdoctoral experience.
Research areas include:
- Cancer genomics
- Cancer and the microbiome
- Computer aided drug design
- Structural biology
- Experimental therapeutics and drug resistance in leukemias
- Tumor immunology and immunotherapy
- Genetic modification of hematopoietic stem cells
- Proteolytic signaling mechanisms in inflammation, tumor and vascular biology
The T32 training program provides a competitive stipend commensurate with qualifications, travel, health insurance, and tuition remission. Appointments to the training grant will be for two years, with the possibility of an extension for another year depending on productivity; support for additional years may be available from the primary research mentor’s grants.
Interested candidates should send or email a letter of intent and Curriculum Vitae to:
UMB T32 Cancer Biology Training Grant
c/o Leanne Simington, MS
University of Maryland Baltimore
Bressler Research Building
655 W. Baltimore Street
Baltimore, MD 21201
Program Directors: Dr. Toni Antalis, PhD and Dr. Curt Civin, MD
Email address: email@example.com
Postdoctoral fellowships are intended for scientists who have a doctoral degree (PhD, MD, MD/PhD, PharmD, DDS or equivalent) or are in the process of completing a doctoral degree. Candidates should have a strong commitment to a career in cancer research.
In accordance with the NIH NRSA eligibility, the candidate must be a United States citizen or permanent resident. Members of underrepresented minority groups are particularly encouraged to apply.